Cargando…

Metabolic engineering of Escherichia coli into a versatile glycosylation platform: production of bio-active quercetin glycosides

BACKGROUND: Flavonoids are bio-active specialized plant metabolites which mainly occur as different glycosides. Due to the increasing market demand, various biotechnological approaches have been developed which use Escherichia coli as a microbial catalyst for the stereospecific glycosylation of flav...

Descripción completa

Detalles Bibliográficos
Autores principales: De Bruyn, Frederik, Van Brempt, Maarten, Maertens, Jo, Van Bellegem, Wouter, Duchi, Dries, De Mey, Marjan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4573293/
https://www.ncbi.nlm.nih.gov/pubmed/26377568
http://dx.doi.org/10.1186/s12934-015-0326-1
_version_ 1782390467676078080
author De Bruyn, Frederik
Van Brempt, Maarten
Maertens, Jo
Van Bellegem, Wouter
Duchi, Dries
De Mey, Marjan
author_facet De Bruyn, Frederik
Van Brempt, Maarten
Maertens, Jo
Van Bellegem, Wouter
Duchi, Dries
De Mey, Marjan
author_sort De Bruyn, Frederik
collection PubMed
description BACKGROUND: Flavonoids are bio-active specialized plant metabolites which mainly occur as different glycosides. Due to the increasing market demand, various biotechnological approaches have been developed which use Escherichia coli as a microbial catalyst for the stereospecific glycosylation of flavonoids. Despite these efforts, most processes still display low production rates and titers, which render them unsuitable for large-scale applications. RESULTS: In this contribution, we expanded a previously developed in vivo glucosylation platform in E. coli W, into an efficient system for selective galactosylation and rhamnosylation. The rational of the novel metabolic engineering strategy constitutes of the introduction of an alternative sucrose metabolism in the form of a sucrose phosphorylase, which cleaves sucrose into fructose and glucose 1-phosphate as precursor for UDP-glucose. To preserve these intermediates for glycosylation purposes, metabolization reactions were knocked-out. Due to the pivotal role of UDP-glucose, overexpression of the interconverting enzymes galE and MUM4 ensured the formation of both UDP-galactose and UDP-rhamnose, respectively. By additionally supplying exogenously fed quercetin and overexpressing a flavonol galactosyltransferase (F3GT) or a rhamnosyltransferase (RhaGT), 0.94 g/L hyperoside (quercetin 3-O-galactoside) and 1.12 g/L quercitrin (quercetin 3-O-rhamnoside) could be produced, respectively. In addition, both strains showed activity towards other promising dietary flavonols like kaempferol, fisetin, morin and myricetin. CONCLUSIONS: Two E. coli W mutants were engineered that could effectively produce the bio-active flavonol glycosides hyperoside and quercitrin starting from the cheap substrates sucrose and quercetin. This novel fermentation-based glycosylation strategy will allow the economically viable production of various glycosides. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12934-015-0326-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4573293
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45732932015-09-18 Metabolic engineering of Escherichia coli into a versatile glycosylation platform: production of bio-active quercetin glycosides De Bruyn, Frederik Van Brempt, Maarten Maertens, Jo Van Bellegem, Wouter Duchi, Dries De Mey, Marjan Microb Cell Fact Research BACKGROUND: Flavonoids are bio-active specialized plant metabolites which mainly occur as different glycosides. Due to the increasing market demand, various biotechnological approaches have been developed which use Escherichia coli as a microbial catalyst for the stereospecific glycosylation of flavonoids. Despite these efforts, most processes still display low production rates and titers, which render them unsuitable for large-scale applications. RESULTS: In this contribution, we expanded a previously developed in vivo glucosylation platform in E. coli W, into an efficient system for selective galactosylation and rhamnosylation. The rational of the novel metabolic engineering strategy constitutes of the introduction of an alternative sucrose metabolism in the form of a sucrose phosphorylase, which cleaves sucrose into fructose and glucose 1-phosphate as precursor for UDP-glucose. To preserve these intermediates for glycosylation purposes, metabolization reactions were knocked-out. Due to the pivotal role of UDP-glucose, overexpression of the interconverting enzymes galE and MUM4 ensured the formation of both UDP-galactose and UDP-rhamnose, respectively. By additionally supplying exogenously fed quercetin and overexpressing a flavonol galactosyltransferase (F3GT) or a rhamnosyltransferase (RhaGT), 0.94 g/L hyperoside (quercetin 3-O-galactoside) and 1.12 g/L quercitrin (quercetin 3-O-rhamnoside) could be produced, respectively. In addition, both strains showed activity towards other promising dietary flavonols like kaempferol, fisetin, morin and myricetin. CONCLUSIONS: Two E. coli W mutants were engineered that could effectively produce the bio-active flavonol glycosides hyperoside and quercitrin starting from the cheap substrates sucrose and quercetin. This novel fermentation-based glycosylation strategy will allow the economically viable production of various glycosides. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12934-015-0326-1) contains supplementary material, which is available to authorized users. BioMed Central 2015-09-16 /pmc/articles/PMC4573293/ /pubmed/26377568 http://dx.doi.org/10.1186/s12934-015-0326-1 Text en © De Bruyn et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
De Bruyn, Frederik
Van Brempt, Maarten
Maertens, Jo
Van Bellegem, Wouter
Duchi, Dries
De Mey, Marjan
Metabolic engineering of Escherichia coli into a versatile glycosylation platform: production of bio-active quercetin glycosides
title Metabolic engineering of Escherichia coli into a versatile glycosylation platform: production of bio-active quercetin glycosides
title_full Metabolic engineering of Escherichia coli into a versatile glycosylation platform: production of bio-active quercetin glycosides
title_fullStr Metabolic engineering of Escherichia coli into a versatile glycosylation platform: production of bio-active quercetin glycosides
title_full_unstemmed Metabolic engineering of Escherichia coli into a versatile glycosylation platform: production of bio-active quercetin glycosides
title_short Metabolic engineering of Escherichia coli into a versatile glycosylation platform: production of bio-active quercetin glycosides
title_sort metabolic engineering of escherichia coli into a versatile glycosylation platform: production of bio-active quercetin glycosides
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4573293/
https://www.ncbi.nlm.nih.gov/pubmed/26377568
http://dx.doi.org/10.1186/s12934-015-0326-1
work_keys_str_mv AT debruynfrederik metabolicengineeringofescherichiacoliintoaversatileglycosylationplatformproductionofbioactivequercetinglycosides
AT vanbremptmaarten metabolicengineeringofescherichiacoliintoaversatileglycosylationplatformproductionofbioactivequercetinglycosides
AT maertensjo metabolicengineeringofescherichiacoliintoaversatileglycosylationplatformproductionofbioactivequercetinglycosides
AT vanbellegemwouter metabolicengineeringofescherichiacoliintoaversatileglycosylationplatformproductionofbioactivequercetinglycosides
AT duchidries metabolicengineeringofescherichiacoliintoaversatileglycosylationplatformproductionofbioactivequercetinglycosides
AT demeymarjan metabolicengineeringofescherichiacoliintoaversatileglycosylationplatformproductionofbioactivequercetinglycosides